Access cutting-edge hiv-1 infection treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access hiv-1 infection specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hiv-1 infection treatment provided free
In the SHIELD study, the study sponsor seeks to assess safety, PK and antiviral activity for children and adolescents with dual or triple class resistance. It will also assess the acceptability and swallowability of formulation among the pediatric population. The dose selection of FTR for children and adolescents ≥20kg utilized a population pharmacokinetic (POP PK) model-based approach to achieve similar adult TMR exposures following FTR 600mg BID administration with combination therapy that was
Sponsor: PENTA Foundation
Check if you qualify for this hiv-1 infection clinical trial in Washington Dc, DC
If you're searching for hiv-1 infection treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv-1 infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.